Skip to main content
Year archive

Evogene Ltd. — 2023 filings

All 144 regulatory filings released by Evogene Ltd. (EVGN) in 2023, sourced directly from the official regulator.

144 Filings
2023 Period
2023 filings (144)
Filing Released Lang
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
Report Publication Announcement
2023-12-21 English
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
Report Publication Announcement
2023-12-21 English
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
Board/Management Information
2023-12-19 English
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
Board/Management Information
2023-12-19 English
6-K
Foreign Filer Report
2023-12-19 English
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos
Regulatory Filings
2023-12-05 English
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos
Report Publication Announcement
2023-12-05 English
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
Regulatory Filings
2023-11-28 English
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
Report Publication Announcement
2023-11-28 English
Evogene Reports First Quarter 2023 Financial Results-Amending the headlines of the financial tables
Interim / Quarterly Report Q1 2023
2023-11-20 English
Evogene Reports First Quarter 2023 Financial Results-Amending the headlines of the financial tables
Report Publication Announcement
2023-11-20 English
Evogene Reports Third Quarter 2023 Financial Results-Technical amendment
Interim / Quarterly Report Q3 2023
2023-11-16 English
Evogene Reports Third Quarter 2023 Financial Results-Technical amendment
Report Publication Announcement Q3 2023
2023-11-16 English
Evogene Reports Third Quarter 2023 Financial Results
Earnings Release Q3 2023
2023-11-15 English
Evogene Reports Third Quarter 2023 Financial Results
Report Publication Announcement
2023-11-15 English
6-K
Foreign Filer Report
2023-11-15 English
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
Regulatory Filings
2023-11-08 English
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
Report Publication Announcement
2023-11-08 English
6-K
Foreign Filer Report
2023-11-08 English
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
Report Publication Announcement
2023-11-02 English
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
Report Publication Announcement
2023-11-02 English
Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology
Regulatory Filings
2023-10-31 Hebrew (modern)
Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology
Report Publication Announcement
2023-10-31 English
Evogene Provides Operational Update Amidst Current Security Situation in Israel
Regulatory Filings
2023-10-18 English
Evogene Provides Operational Update Amidst Current Security Situation in Israel
Regulatory Filings
2023-10-18 English
Casterra Delivers First Shipment of Castor Seeds to Africa
Earnings Release Q2 2023
2023-09-27 English
Casterra Delivers First Shipment of Castor Seeds to Africa
Report Publication Announcement
2023-09-27 English
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Regulatory Filings
2023-09-21 English
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification
Report Publication Announcement
2023-09-21 English
6-K
Foreign Filer Report
2023-09-21 English
Castera - Company Presentation
Investor Presentation
2023-09-19 English
Castera - Company Presentation
Report Publication Announcement
2023-09-19 English
6-K
Foreign Filer Report
2023-09-19 English
Unaudited Condensed Consolidated Interim Financial Statements for the Six Months Ended June 30, 2023
Interim / Quarterly Report H1 2023
2023-09-13 English
Unaudited Condensed Consolidated Interim Financial Statements for the Six Months Ended June 30, 2023
Report Publication Announcement H1 2023
2023-09-13 English
6-K
Foreign Filer Report
2023-09-13 English
Lavie Bio Investor Presentation
Investor Presentation
2023-08-23 English
Lavie Bio Investor Presentation
Investor Presentation
2023-08-23 English
6-K
Foreign Filer Report
2023-08-23 English
Evogene Reports Second Quarter 2023 Financial Results
Earnings Release Q2 2023
2023-08-17 English
Evogene Reports Second Quarter 2023 Financial Results
Report Publication Announcement Q2 2023
2023-08-17 English
6-K
Foreign Filer Report
2023-08-17 English
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
Regulatory Filings
2023-08-15 English
Biomica Opens Second Site to Advance Its Immuno-Oncology Drug Trials at Davidoff Center
Report Publication Announcement
2023-08-15 English
Ag Plenus Investor Presentation
Investor Presentation
2023-08-08 English
Ag Plenus Investor Presentation
Report Publication Announcement
2023-08-08 English
6-K
Foreign Filer Report
2023-08-08 English
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
Report Publication Announcement
2023-07-31 English
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
Report Publication Announcement
2023-07-31 English
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery
Regulatory Filings
2023-07-25 English
Evogene's ChemPass AI Tech-Engine is Introduced with New Breakthrough Machine Learning Technology for Target-Protein Discovery
Regulatory Filings
2023-07-25 English
Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program
Earnings Release Q3 2023
2023-07-19 English
Biomica Announces Interim Positive Results from Pre-Clinical Studies in its Irritable Bowel Syndrome (IBS) Program
Report Publication Announcement
2023-07-19 English
prospectus supplement date July 17, 2023
Capital/Financing Update
2023-07-18 English
prospectus supplement date July 17, 2023
Report Publication Announcement
2023-07-18 English
424B5
Prospectus
2023-07-18 English
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering
Regulatory Filings
2023-07-17 English
Evogene Announces Pricing of US$8,500,000 Registered Direct Offering
Capital/Financing Update
2023-07-17 English
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
Regulatory Filings
2023-07-17 English
Evogene Regains Compliance with Nasdaq Minimum Closing Bid Price Rule
Report Publication Announcement
2023-07-17 English
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience
Regulatory Filings
2023-07-17 English
Lavie Bio Announces Licensing Agreement for Bio-Fungicides with Corteva Agriscience
Regulatory Filings
2023-07-17 English
6-K
Foreign Filer Report
2023-07-17 English
6-K
Foreign Filer Report
2023-07-17 English
6-K
Foreign Filer Report
2023-07-17 English
Trading in the company's shares was halted until the completion of pricing in U.S.
Regulatory Filings
2023-07-17 Hebrew (modern)
AgPlenus Appoints Dr. Adrian Percy to Its Board of Directors
Board/Management Information
2023-07-12 English
AgPlenus Appoints Dr. Adrian Percy to Its Board of Directors
Report Publication Announcement
2023-07-12 English
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories
Regulatory Filings
2023-07-03 English
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories
Report Publication Announcement
2023-07-03 English
6-K
Foreign Filer Report
2023-07-03 English
Casterra Signs a Framework Agreement with a World Leading Oil and Gas Company to Sell Its Castor Seeds for Sustainable Biofuel Production, with Initial Purchase Orders of $9.1 Million
Regulatory Filings
2023-06-21 English
Casterra Signs a Framework Agreement with a World Leading Oil and Gas Company to Sell Its Castor Seeds for Sustainable Biofuel Production, with Initial Purchase Orders of $9.1 Million
Report Publication Announcement
2023-06-21 English
6-K
Foreign Filer Report
2023-06-21 English
Lavie Bio Receives Canadian Regulatory Approval for Thrivus™, Expanding Global Reach
Regulatory Filings
2023-05-24 English
Lavie Bio Receives Canadian Regulatory Approval for Thrivus™, Expanding Global Reach
Report Publication Announcement
2023-05-24 English
Investor Presentation
Investor Presentation
2023-05-18 English
Investor Presentation
Investor Presentation
2023-05-18 English
Evogene Reports First Quarter 2023 Financial Results
Interim / Quarterly Report Q1 2023
2023-05-18 English
Evogene Reports First Quarter 2023 Financial Results
Report Publication Announcement
2023-05-18 English
The company's first quarter 2023 financial results reported abroad
Regulatory Filings
2023-05-18 Hebrew (modern)
6-K
Foreign Filer Report
2023-05-18 English
6-K
Foreign Filer Report
2023-05-18 English
Results of Annual General Meeting held on May 11, 2023
Regulatory Filings
2023-05-12 English
Results of Annual General Meeting held on May 11, 2023
Report Publication Announcement
2023-05-12 English
6-K
Foreign Filer Report
2023-05-11 English
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant
Regulatory Filings
2023-05-09 English
Evogene Ag-Seed Division Awarded Prestigious €1.2M Horizon Grant
Report Publication Announcement
2023-05-09 English
6-K
Foreign Filer Report
2023-05-09 English
Adjournment of Annual General Meeting Will be held on the day Thursday on the date : 11/05/2023
Proxy Solicitation & Information Statement
2023-05-05 English
Adjournment of Annual General Meeting Will be held on the day Thursday on the date : 11/05/2023
AGM Information
2023-05-05 English
Adjournment of Annual General Meeting
Regulatory Filings
2023-05-05 English
Adjournment of Annual General Meeting
Report Publication Announcement
2023-05-05 English
6-K
Foreign Filer Report
2023-05-04 English
First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023
Earnings Release Q1 2023
2023-05-04 English
First Quarter 2023 Financial Results Release & Conference Call for May 18, 2023
Report Publication Announcement
2023-05-04 English
Evogene Reports Receipt of Nasdaq Minimum Bid Price Extension Period Notification, the Company’s ordinary shares were transferred to the Nasdaq Capital Market
Regulatory Filings
2023-05-03 English
Evogene Reports Receipt of Nasdaq Minimum Bid Price Extension Period Notification, the Company’s ordinary shares were transferred to the Nasdaq Capital Market
Report Publication Announcement
2023-05-03 English
6-K
Foreign Filer Report
2023-05-03 English
Plantis Licenses Two of Canonic's Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market
Regulatory Filings
2023-05-02 English
Plantis Licenses Two of Canonic's Proprietary Cannabis Varieties to Expand its Offerings in the Israeli Market
Report Publication Announcement
2023-05-02 English
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
Capital/Financing Update
2023-04-27 English
Biomica Announces Closing of $20 Million Financing Round led by Shanghai Healthcare Capital
Capital/Financing Update
2023-04-27 English
6-K
Foreign Filer Report
2023-04-27 English
NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 4, 2023
Proxy Solicitation & Information Statement
2023-03-31 English
NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 4, 2023
AGM Information
2023-03-31 English
NOTICE OF 2023 ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 4, 2023
AGM Information
2023-03-31 English
Form 20-F - ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021
Annual Report FY 2022
2023-03-31 English
Form 20-F - ANNUAL REPORT FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021
Report Publication Announcement
2023-03-31 English
6-K
Foreign Filer Report
2023-03-30 English
20-F
Annual Report FY 2022
2023-03-30 English
Lavie Bio(subsidiary) Announces Appointment of Amit Noam as its Incoming Chief Executive Officer
Board/Management Information
2023-03-30 English
Lavie Bio(subsidiary) Announces Appointment of Amit Noam as its Incoming Chief Executive Officer
Board/Management Information
2023-03-30 English
6-K/A
Foreign Filer Report
2023-03-30 English
Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer
Board/Management Information
2023-03-29 English
Lavie Bio Announces Appointment of Amit Noam as its Incoming Chief Executive Officer
Board/Management Information
2023-03-29 English
6-K
Foreign Filer Report
2023-03-29 English
Biomica VP R&D to Present at the Pharmabiotics 2023 Conference on March 21, 2023
Regulatory Filings
2023-03-16 English
Biomica VP R&D to Present at the Pharmabiotics 2023 Conference on March 21, 2023
Report Publication Announcement
2023-03-16 English
Reports Fourth Quarter and Full Year 2022 Financial Results
Earnings Release FY 2022
2023-03-09 English
Reports Fourth Quarter and Full Year 2022 Financial Results
Report Publication Announcement
2023-03-09 English
6-K
Foreign Filer Report
2023-03-09 English
Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco
Report Publication Announcement
2023-03-06 English
Lavie Bio to Host a Round Table Discussion and is a Sponsor at World Agri-Tech Conference in San Francisco
Report Publication Announcement
2023-03-06 English
AgPlenus to Attend World Agri-Tech Conference in San Francisco
Regulatory Filings
2023-03-06 English
AgPlenus to Attend World Agri-Tech Conference in San Francisco
Report Publication Announcement
2023-03-06 English
Biomica CSO to Present at the ECCO 2023 Annual Meeting in Copenhagen between March 1-4, 2023
Regulatory Filings
2023-03-01 English
Biomica CSO to Present at the ECCO 2023 Annual Meeting in Copenhagen between March 1-4, 2023
Report Publication Announcement
2023-03-01 English
Evogene to Attend the Annual ROTH Investor Conference in California on March 13, 2023
Report Publication Announcement
2023-03-01 English
Evogene to Attend the Annual ROTH Investor Conference in California on March 13, 2023
Regulatory Filings
2023-03-01 English
Lavie Bio Reports Successful Results for its Bio-Fungicides Programs
Regulatory Filings
2023-02-28 English
Lavie Bio Reports Successful Results for its Bio-Fungicides Programs
Regulatory Filings
2023-02-28 English
Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023
Report Publication Announcement
2023-02-27 English
Schedules Fourth Quarter and Full Year 2022 Financial Results Release & Conference Call for March 9, 2023
Report Publication Announcement
2023-02-27 English
Canonic Successfully Launched Six Second-Generation Cannabis Products with Higher THC and Rich Terpene Profiles
Regulatory Filings
2023-02-21 English
Canonic Successfully Launched Six Second-Generation Cannabis Products with Higher THC and Rich Terpene Profiles
Report Publication Announcement
2023-02-21 English
Biomica CEO to Participate in Panel Discussion at 7th European Annual Microbiome Movement
Regulatory Filings
2023-01-24 English
Biomica CEO to Participate in Panel Discussion at 7th European Annual Microbiome Movement
Regulatory Filings
2023-01-24 English
Casterra Announces Agreement with World Leading Energy Company to Cultivate its Castor Varieties at Commercial Scale
Regulatory Filings
2023-01-19 English
Casterra Announces Agreement with World Leading Energy Company to Cultivate its Castor Varieties at Commercial Scale
Regulatory Filings
2023-01-19 English
6-K
Foreign Filer Report
2023-01-19 English
Changes in the management of Lavie Bio
Board/Management Information
2023-01-12 English
Changes in the management of Lavie Bio
Report Publication Announcement
2023-01-12 English
6-K
Foreign Filer Report
2023-01-12 English